Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Journal of Toxicology and Environmental Health
|
November 1, 1975
Dissociation of mutagenic and other toxic properties from schistosomicides
E Bueding
The Journal of Parasitology
|
April 1, 1982
Metabolic requirements of schistosomes
E Bueding, J Fisher
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1977
Mutagenic activities in vitro and in vivo of five antischistosomal compounds
R P Batzinger, E Bueding
The Journal of Parasitology
|
February 1, 1979
Glycogen synthase of Hymenolepis diminuta. II. Nutritional state, interconversion of forms, and primer glycogen molecular weight as control factors
P A Mied, E Bueding
Journal of Chromatography
|
August 12, 1983
Identification and quantitation of a metabolite of anethol dithiolthione in rat and mouse urine using high-performance liquid chromatography
A N Masoud, E Bueding
The Journal of Parasitology
|
February 1, 1979
Glycogen synthase Hymenolepis diminuta. I. Allosteric activation and inhibition
P A Mied, E Bueding
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1978
Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540)
Y N Cha, E Bueding
Science (New York, N.Y.)
|
June 4, 1971
Hycanthone resistance: development in Schistosoma mansoni
S H Rogers, E Bueding
Carcinogenesis
|
August 1, 1986
Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard
L W Wattenberg, E Bueding
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1976
Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni
W H Haese, E Bueding
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Journal of Toxicology and Environmental Health
|
November 1, 1975
Dissociation of mutagenic and other toxic properties from schistosomicides
E Bueding
The Journal of Parasitology
|
April 1, 1982
Metabolic requirements of schistosomes
E Bueding, J Fisher
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1977
Mutagenic activities in vitro and in vivo of five antischistosomal compounds
R P Batzinger, E Bueding
The Journal of Parasitology
|
February 1, 1979
Glycogen synthase of Hymenolepis diminuta. II. Nutritional state, interconversion of forms, and primer glycogen molecular weight as control factors
P A Mied, E Bueding
Journal of Chromatography
|
August 12, 1983
Identification and quantitation of a metabolite of anethol dithiolthione in rat and mouse urine using high-performance liquid chromatography
A N Masoud, E Bueding
The Journal of Parasitology
|
February 1, 1979
Glycogen synthase Hymenolepis diminuta. I. Allosteric activation and inhibition
P A Mied, E Bueding
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1978
Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540)
Y N Cha, E Bueding
Science (New York, N.Y.)
|
June 4, 1971
Hycanthone resistance: development in Schistosoma mansoni
S H Rogers, E Bueding
Carcinogenesis
|
August 1, 1986
Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard
L W Wattenberg, E Bueding
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1976
Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni
W H Haese, E Bueding
Page
of 5